SEC Form 4 · accession 0001013606-18-000031
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D McDermott
Officer — Chief Executive Officer · Director
Period of report
Mar 13, 2018
Accepted (ET)
Mar 15, 2018 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 13, 2018 | D | 140,000 | $0.00 | D | 588,659 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares subject to this Form 4 were granted as part of a performance restricted stock unit granted May 31, 2017. All shares granted have been forfeited due to the single performance milestone being deemed not achievable by the Company.